Literature DB >> 7376941

Evaluation of the humoral response of meningioma patients to possible common tumour-associated antigens.

S Mottet, A Martin-Achard, N de Tribolet, A C Diserens.   

Abstract

The humoral response of 39 meningioma patients to possible tumourassociated antigens was studied by means of an antibody dependent cell mediated cytotoxicity test (ADCC). Five patients were found to have cytotoxic antibodies against 1 to 10 meningioma cell lines. However, three of these were also cytotoxic against malignant glioma cell lines but not against other unrelated tumours. These results suggest the existence of surface antigens common to meningiomas and gliomas.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7376941     DOI： 10.1007/bf01400942

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


  16 in total

1.  Establishment of a cell line (Co-115) from a human colon carcinoma transplanted into nude mice.

Authors:  S Carrel; B Sordat; C Merenda
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

2.  In vitro demonstration of cell-mediated immunity to human brain tumors.

Authors:  N L Levy; M S Mahaley; E D Day
Journal:  Cancer Res       Date:  1972-03       Impact factor: 12.701

3.  Demonstration of cell-mediated immunity to human neoplasms of various histological types.

Authors:  I Hellström; K E Hellström; H O Sjögren; G A Warner
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

4.  Long term culture of normal and neoplastic human glia.

Authors:  J Pontén; E H Macintyre
Journal:  Acta Pathol Microbiol Scand       Date:  1968

5.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

6.  Human meningioma antigens.

Authors:  W D Winters; J R Rich
Journal:  Int J Cancer       Date:  1975-05-15       Impact factor: 7.396

7.  Soluble membrane antigens of brain tumors. I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient.

Authors:  M H Hitchcock; A C Hollinshead; P Chretien; H V Rizzoli
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

8.  Cell-mediated immune response of patients with meningiomas defined in vitro by a [3H]proline microcytotoxicity test.

Authors:  H W Pees; B Seidel
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

9.  Common antigen in meningioma-derived cell cultures.

Authors:  L W Catalano; D H Harter; K C Hsu
Journal:  Science       Date:  1972-01-14       Impact factor: 47.728

10.  Cytotoxic immune response of meningioma patients towards allogeneic and autologous tumour cells before and after surgery.

Authors:  H W Pees
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216
View more
  4 in total

1.  Immunopathological significance of IgG in meningioma in relation to the pseudopsammoma bodies.

Authors:  J Kuratsu; Y Matsukado; R Hattori; S Nagahiro
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

2.  The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.

Authors:  M L Apuzzo; K M Sheikh; M H Weiss; J S Heiden; T Kurze
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

3.  Immunohistochemical demonstration of IgG in meningioma.

Authors:  K Tabuchi; Y Kawakami; A Nishimoto
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

4.  Electron-microscopic visualization of binding of antibodies from sera of glioma patients on cultured glioma cells.

Authors:  G M Lauro; C Solheid; L Medolago-Albani; N Di Lorenzo; B Guidetti
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.